366 related articles for article (PubMed ID: 8844209)
61. Ethical aspects of genetic screening in Israel.
Sagi M
Sci Context; 1998; 11(3-4):419-29. PubMed ID: 15168671
[TBL] [Abstract][Full Text] [Related]
62. More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.
Hechtman P; Kaplan F; Bayleran J; Boulay B; Andermann E; de Braekeleer M; Melançon S; Lambert M; Potier M; Gagné R
Am J Hum Genet; 1990 Nov; 47(5):815-22. PubMed ID: 2220821
[TBL] [Abstract][Full Text] [Related]
63. Improving accuracy of Tay Sachs carrier screening of the non-Jewish population: analysis of 34 carriers and six late-onset patients with HEXA enzyme and DNA sequence analysis.
Park NJ; Morgan C; Sharma R; Li Y; Lobo RM; Redman JB; Salazar D; Sun W; Neidich JA; Strom CM
Pediatr Res; 2010 Feb; 67(2):217-20. PubMed ID: 19858779
[TBL] [Abstract][Full Text] [Related]
64. Multiplexed fluorescence analysis for mutations causing Tay-Sachs disease.
Stockley TL; Ray PN
Methods Mol Biol; 2003; 217():131-41. PubMed ID: 12491928
[No Abstract] [Full Text] [Related]
65. The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
Hou Y; Vavougios G; Hinek A; Wu KK; Hechtman P; Kaplan F; Mahuran DJ
Am J Hum Genet; 1996 Jul; 59(1):52-8. PubMed ID: 8659543
[TBL] [Abstract][Full Text] [Related]
66. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
Buchalter MS; Wannmacher CM; Wajner M
J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
[TBL] [Abstract][Full Text] [Related]
67. Mendelian diseases among Roman Jews: implications for the origins of disease alleles.
Oddoux C; Guillen-Navarro E; Ditivoli C; Dicave E; Cilio MR; Clayton CM; Nelson H; Sarafoglou K; McCain N; Peretz H; Seligsohn U; Luzzatto L; Nafa K; Nardi M; Karpatkin M; Aksentijevich I; Kastner D; Axelrod F; Ostrer H
J Clin Endocrinol Metab; 1999 Dec; 84(12):4405-9. PubMed ID: 10599695
[TBL] [Abstract][Full Text] [Related]
68. Prenatal diagnosis of a Japanese family at risk for Tay-Sachs disease. Application of a fluorescent competitive allele-specific polymerase chain reaction (PCR) method.
Tamasu S; Nishio H; Ayaki H; Lee MJ; Mizutori M; Takeshima Y; Nakamura H; Matsuo M; Maruo T; Sumino K
Kobe J Med Sci; 1999 Dec; 45(6):259-70. PubMed ID: 10985159
[TBL] [Abstract][Full Text] [Related]
69. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model.
Kaback MM
Eur J Pediatr; 2000 Dec; 159 Suppl 3():S192-5. PubMed ID: 11216898
[TBL] [Abstract][Full Text] [Related]
70. Development of genomic DNA reference materials for genetic testing of disorders common in people of ashkenazi jewish descent.
Kalman L; Wilson JA; Buller A; Dixon J; Edelmann L; Geller L; Highsmith WE; Holtegaard L; Kornreich R; Rohlfs EM; Payeur TL; Sellers T; Toji L; Muralidharan K
J Mol Diagn; 2009 Nov; 11(6):530-6. PubMed ID: 19815695
[TBL] [Abstract][Full Text] [Related]
71. A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
Ohno K; Suzuki K
Biochem Biophys Res Commun; 1988 May; 153(1):463-9. PubMed ID: 2837213
[TBL] [Abstract][Full Text] [Related]
72. Ethical Issues with Genetic Testing for Tay-Sachs.
Clayton T
J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
[TBL] [Abstract][Full Text] [Related]
73. [Tay-Sachs disease].
Tanaka A
Nihon Rinsho; 1993 Sep; 51(9):2281-5. PubMed ID: 8411703
[TBL] [Abstract][Full Text] [Related]
74. The presence of two different infantile Tay-Sachs disease mutations in a Cajun population.
McDowell GA; Mules EH; Fabacher P; Shapira E; Blitzer MG
Am J Hum Genet; 1992 Nov; 51(5):1071-7. PubMed ID: 1307230
[TBL] [Abstract][Full Text] [Related]
75. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease.
Akli S; Chelly J; Mezard C; Gandy S; Kahn A; Poenaru L
J Biol Chem; 1990 May; 265(13):7324-30. PubMed ID: 2139660
[TBL] [Abstract][Full Text] [Related]
76. Introduction of the alpha subunit mutation associated with the B1 variant of Tay-Sachs disease into the beta subunit produces a beta-hexosaminidase B without catalytic activity.
Brown CA; Neote K; Leung A; Gravel RA; Mahuran DJ
J Biol Chem; 1989 Dec; 264(36):21705-10. PubMed ID: 2532211
[TBL] [Abstract][Full Text] [Related]
77. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
[TBL] [Abstract][Full Text] [Related]
78. A glycine250--> aspartate substitution in the alpha-subunit of hexosaminidase A causes juvenile-onset Tay-Sachs disease in a Lebanese-Canadian family.
Trop I; Kaplan F; Brown C; Mahuran D; Hechtman P
Hum Mutat; 1992; 1(1):35-9. PubMed ID: 1301189
[TBL] [Abstract][Full Text] [Related]
79. Primer system for single cell detection of double mutation for Tay-Sachs disease.
Liu MC; Drury KC; Kipersztok S; Zheng W; Williams RS
J Assist Reprod Genet; 2000 Feb; 17(2):121-6. PubMed ID: 10806593
[TBL] [Abstract][Full Text] [Related]
80. Different mutations in Ashkenazi Jewish and non-Jewish French Canadians with Tay-Sachs disease.
Myerowitz R; Hogikyan ND
Science; 1986 Jun; 232(4758):1646-8. PubMed ID: 3754980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
